No Data
No Data
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Candel Therapeutics CADL, a clinical-stage oncology company, is focused on developing two novel therapeutics, CAN-2409 and CAN-3110, to treat a variety of cancer indications.
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersCue Health (NASDAQ:HLTH) stock moved upwards by 32.4% to $0.12 during Monday's pre-market session. The market value of their outstanding shares is at $19.8 million. SCWorx (NASDAQ:WORX) shares
Express News | Candel Therapeutics Shares Down 21%
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast fo
Express News | Candel Therapeutics Shares up 19.3% Premarket on Positive Mid-Stage Trial Data for Lung Cancer Treatment
Candel Therapeutics' CAN-2409 Enhances NSCLC Survival In Phase 2 Trial; Stock Surges
No Data